Sodium-glucose co-transporter 2 inhibition and acute myocardial infarction: the DAPA-MI and EMPACT-MI trials.
| Autor: | Zaman MA; Internal Medicine Department, Conemaugh Health System, Johnstown, PA, USA., Kalsoom S; Cardiology Department, Mercy Health Saint Vincent Medical Center, Toledo, OH, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2024 Sep; Vol. 17 (9), pp. 771-775. Date of Electronic Publication: 2024 Aug 12. |
| DOI: | 10.1080/17512433.2024.2390921 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|